Investigating how sodium-activated potassium channels affect brain function and autism.
Cellular Regulation of Sodium-activated Potassium Channels
This study is looking at a gene called KCNT1 to see how changes in it might affect brain activity and contribute to conditions like childhood epilepsy and autism, using mouse models to help us learn more about how these issues happen.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10984464 on NIH RePORTER |
What this research studies
This research focuses on the KCNT1 gene, which is linked to sodium-activated potassium channels that play a crucial role in neuronal activity. By studying mouse models with specific mutations in this gene, the research aims to understand how these mutations lead to increased potassium currents and contribute to conditions like childhood epilepsy and autism. The approach includes using advanced techniques such as in situ hybridization and antisense oligonucleotides to manipulate the expression of different channel isoforms, providing insights into their roles in brain function. This could lead to a better understanding of the underlying mechanisms of these disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are children diagnosed with autism spectrum disorders or childhood epilepsy linked to KCNT1 mutations.
Not a fit: Patients without mutations in the KCNT1 gene or those with unrelated neurological conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating childhood epilepsy and autism spectrum disorders.
How similar studies have performed: Previous research has shown promising results in understanding the role of potassium channels in neuronal function, suggesting that this approach could yield valuable insights.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Kaczmarek, Leonard K — Yale University
- Study coordinator: Kaczmarek, Leonard K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.